Merck KGaA’s varied track & trace approach: 'We cannot rely on a singular security feature'

By Flora Southey contact

- Last updated on GMT


Related tags: Authentication, Merck kgaa

Merck KGaA says using a variety of tracking and authentication technologies and engaging with patients are vital to creating secure supply chains. 

At serialisation conference Nexus 17, ​held in Barcelona, Spain in June, Merck KGaA spokesman Andreas Pies said “We cannot rely on a singular security feature.”

Instead, the firm has incorporated proprietary technologies, including pigmented packaging and anti-counterfeiting platforms, to complement serialisation regulations.

Functional pigments

The implementation of functional pigments – manufactured by Merck’s specialty chemicals business - is one such security feature.

According to the firm, specialised pigments in product packaging enable simple identification and counterfeit protection.

“One additive enables razor-sharp laser markings and another facilitates easy product tracking, so items can be labelled and followed through the entire supply chain,” ​said the firm.

According to Pies, who heads up global engineering and technology at Merck Serono, the pigment allows Merck to “identify, via this pigment on our boxes, that a product has been produced by us, and is part of a secure production chain.”

Patient engagement

Pies said Merck is also increasing supply chain security via improved manufacturer-patient engagement.

“We are now expanding further to proceed with our anti-counterfeiting strategy, starting now with the first elements beyond the pure compliance requirements, to include our patients,” ​he said.

Merck’s software tool, Check My Meds​ – live since December 2014 in the US and since Q1 2017 in Colombia - allows patients to use their mobile phone to verify the barcode of Merck-made products, before taking the medications, Pies explained.

“This is very important in countries in particular, where we are facing higher levels of fake medicines and counterfeit products.”

“We have started with suppliers in the US and recently launched ​[Check My Meds] in Colombia, and are expanding further,” ​said Pies.

Pies said further developments and launches of the Check My Meds phone application is foreseen.

Related news

Show more

Related products

show more

A Culture of Innovation as a Differentiation

A Culture of Innovation as a Differentiation

Softigel by Procaps | 06-Dec-2021 | Product Presentation

We create safe, effective and differentiated pharmaceutical solutions and this has been our goal since day 1. The main driver of our growth is innovation...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Related suppliers

Follow us


View more